Pegasystems (NASDAQ: PEGA) awards director stock, options
Rhea-AI Filing Summary
PEGASYSTEMS INC (PEGA) reported that Director Peter Gyenes received equity compensation for his annual board term. He was granted 3,868 shares of unrestricted common stock and a fully vested non-statutory stock option for 7,947 shares of common stock at an exercise price of $32.32 per share, expiring on 2036-08-15. Following these grants, he directly holds 30,586 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 3,868 shares
Net Buy
2 txns
Insider
GYENES PETER
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options F2 | 7,947 | $0.00 | $0.00 |
| Grant/Award | Common stock F1 | 3,868 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options — 7,947 shares (Direct);
Common stock — 30,586 shares (Direct)
Footnotes (2)
- F1. Represents shares of unrestricted common stock received as consideration for the reporting person's service as a Director for the annual term.
- F2. Non-statutory stock option fully vested on issuance and granted as consideration for the reporting person's services as a Director for the annual term.
Key Figures
Unrestricted common shares granted: 3,868 shares
Options granted (underlying shares): 7,947 shares
Option exercise price: $32.32 per share
+3 more
6 metrics
Unrestricted common shares granted
3,868 shares
Shares of unrestricted common stock received as consideration for service as Director for the annual term
Options granted (underlying shares)
7,947 shares
Non-statutory stock option fully vested on issuance for service as Director for the annual term
Option exercise price
$32.32 per share
Conversion or exercise price of the non-statutory stock option granted on 2026-08-15
Option expiration date
2036-08-15
Expiration date of the non-statutory stock option for 7,947 shares
Common shares held after transaction
30,586 shares
Total direct PEGA common stock holdings by Peter Gyenes following the 3,868-share grant
Grant date
2026-08-15
Transaction date for both the unrestricted stock grant and the stock option grant
Key Terms
unrestricted common stock, Non-statutory stock option, fully vested on issuance
3 terms
unrestricted common stock financial
"Represents shares of unrestricted common stock received as consideration"
Non-statutory stock option financial
"Non-statutory stock option fully vested on issuance and granted"
A non-statutory stock option is a company-granted right that lets a person buy shares later at a set price but does not receive special tax-favored treatment under tax law. It matters to investors because when the option is used the holder usually pays ordinary income tax on the gain and the company records compensation cost and issues new shares, which can reduce existing owners’ percentage ownership—think of it like a coupon to buy stock that creates a taxable event and some dilution.
fully vested on issuance financial
"Non-statutory stock option fully vested on issuance and granted"
FAQ
What equity awards did PEGA Director Peter Gyenes receive in this Form 4?
Peter Gyenes received 3,868 shares of unrestricted PEGA common stock and a non-statutory stock option for 7,947 shares. Both awards were granted as consideration for his service as a Director for the annual term.
What is the exercise price and term of the new stock options granted to the PEGA director?
The newly granted non-statutory stock options have an exercise price of $32.32 per share and an expiration date of 2036-08-15. The filing states these options were fully vested on issuance as compensation for the director’s annual term.
Were the PEGA equity awards to Director Peter Gyenes part of regular board compensation?
Yes. The filing states the 3,868 unrestricted shares and the fully vested non-statutory stock option for 7,947 shares were granted as consideration for Peter Gyenes’ services as a Director for the annual term.
Does this PEGA Form 4 indicate any stock sales or dispositions by Peter Gyenes?
No. The Form 4 reports only acquisitions: grants of 3,868 unrestricted shares and options for 7,947 shares. The transaction summary shows acquireCount 2 and disposeCount 0, with no reported sales or other dispositions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
